by Jakub Jarolím, Business Intelligence Department
Dear customer, we are sorry but your browser doesn't support all necessary features for good site view. Please switch to one of the modern browsers (Chrome, Safari, Firefox).
Sotio Biotech
27/2/2022
January 2022 Biotechnology: Review of news from the most innovative therapeutic areas and the business development transactions
Market
Stocks had a lousy start to the year, but Wall Street expects good times ahead
Stocks had a lousy start to the year, and even though January is considered as the whole year’s barometer, Wall Street expects good times ahead.
Antibody-Drug Conjugates
Sutro announced positive Phase 1 results of its STRO-002 ADC in ovarian cancer
RemeGen said China’s FDA expanded the label of ADC disitamab vedotin by granting conditional approval to treat HER2-expressing, locally advanced or metastatic urothelial carcinoma.
The agency had already granted the ADC conditional approval in June 2021 for gastric cancer. Seagen paid $200 million upfront in August to obtain most global rights to disitamab vedotin, which the partners believe uses a mAb with higher HER2 affinity than Herceptin trastuzumab.
Interleukin-15 and Interleukin-2
Stock of Cue fell after posting negative early combo data of its IL-2 with Keytruda in HNC
ImmunityBio announced promising results for HIV cure strategy with Anktiva therapy
Cell Therapies
EMA recommended use of Breyanzi CAR-T therapy in patients with DLBCL
The EMA’s Committee for Medicinal Products for Human Use’s scientific committee recommended Breyanzi (lisocabtagene maraleucel) CAR T-cell therapy can be used to treat adults with DLBCL, primary mediastinal large B-cell lymphoma (PMBCL) and follicular lymphoma grade 3B (FL3B).
Other Innovative Treatment Areas
BeiGene’s Tislelizumab meets its endpoint in Phase 3 in gastric cancer
Tislelizumab from BeiGene met its primary endpoint of overall survival in a Phase 3 trial to treat patients with locally advanced, unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma also being treated with chemotherapy.
Share on social networks